Results underscore clinical utility of novel circulating tumor DNA assay to detect disease recurrence Clinical Genomics, a private company developing innovative diagnostic tools for colorectal cancer, ...
Clinical Genomics has launched a blood-based test for monitoring colorectal cancer recurrence called Colvera, the company announced. “Current professional guidelines recommend inclusion of the ...
Assessing Surveillance Utilization and Value in Commercially Insured Patients With Colorectal Cancer
Trends in surveillance testing after treatment for colorectal cancer remained relatively stable recently, and patients who overutilized surveillance measures had quicker recurrence detection but ...
PITTSBURGH--(BUSINESS WIRE)--RedPath Integrated Pathology, Inc., a leader in molecular diagnostics, announced the launch of a new, patent-pending, customized test to accurately measure ...
NEW YORK (Reuters Health) - The results of new research indicate that many older patients who survive colorectal cancer do not attend the guideline-recommended follow-up office visits or undergo ...
LONDON, June 29, 2017 /PRNewswire/ -- The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover ...
Retrospective health care claims database analysis of direct medical costs of newly diagnosed patients (pts) with hepatocellular carcinoma (HCC) in the United States. Background: Relapse after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback